$4.65
▲ $0.20 (+4.5%)
LXEO
Lexeo Therapeutics, Inc.
Health Care
Investor Score
39F
Weak rating
Based on 6 of 7 weighted categories, computed from real, live financial data only.
21
Technical
46
Fundamental
46
Growth
38
Fair Value
56
News
—
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.